Cite
Kronik Subdural Hematom Hastalarında Klinik Özellikler: Travma ve Antikoagülan/Antiagregan İlaç Kullanımı, Clinical Features in Chronic Subdural Hematoma Patients: Trauma and Anticoagulant / Antiagregan Drug Used
MLA
Uçkun, Özhan, et al. Kronik Subdural Hematom Hastalarında Klinik Özellikler: Travma ve Antikoagülan/Antiagregan İlaç Kullanımı, Clinical Features in Chronic Subdural Hematoma Patients: Trauma and Anticoagulant / Antiagregan Drug Used. June 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.tubitakulakb..c230da43763ed69ae0416f9221da95fe&authtype=sso&custid=ns315887.
APA
Uçkun, Ö., Di̇vanlioğlu, D., Dağlioğlu, E., Alagöz, F., Dalgiç, A., & Belen, A. D. (2018). Kronik Subdural Hematom Hastalarında Klinik Özellikler: Travma ve Antikoagülan/Antiagregan İlaç Kullanımı, Clinical Features in Chronic Subdural Hematoma Patients: Trauma and Anticoagulant / Antiagregan Drug Used.
Chicago
Uçkun, Özhan, Denizhan Di̇vanlioğlu, Ergün Dağlioğlu, Fatih Alagöz, Ali Dalgiç, and Ahmet Deniz Belen. 2018. “Kronik Subdural Hematom Hastalarında Klinik Özellikler: Travma ve Antikoagülan/Antiagregan İlaç Kullanımı, Clinical Features in Chronic Subdural Hematoma Patients: Trauma and Anticoagulant / Antiagregan Drug Used,” June. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.tubitakulakb..c230da43763ed69ae0416f9221da95fe&authtype=sso&custid=ns315887.